News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,034 Results
Type
Article (88286)
Company Profile (812)
Press Release (785915)
Multimedia
Podcasts (213)
Webinars (34)
Section
Business (233383)
Career Advice (4153)
Deals (39903)
Drug Delivery (160)
Drug Development (91510)
Employer Resources (206)
FDA (18464)
Job Trends (17448)
News (398229)
Policy (40003)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3030)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (169)
Alliances (56984)
ALS (202)
Alzheimer's disease (1864)
Antibody-drug conjugate (ADC) (401)
Approvals (18671)
Artificial intelligence (714)
Autoimmune disease (233)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (486)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (721)
Cancer (5535)
Cardiovascular disease (490)
Career advice (3581)
Career pathing (45)
CAR-T (324)
CDC (69)
Celiac Disease (2)
Cell therapy (897)
Cervical cancer (42)
Clinical research (77666)
Collaboration (2021)
Company closure (6)
Compensation (1282)
Complete response letters (91)
COVID-19 (3010)
CRISPR (110)
C-suite (1014)
Cystic fibrosis (157)
Data (7003)
Decentralized trials (2)
Denatured (79)
Depression (173)
Diabetes (580)
Diagnostics (7380)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (347)
Drug pricing (233)
Drug shortages (36)
Duchenne muscular dystrophy (283)
Earnings (101066)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136240)
Executive appointments (1095)
FDA (21936)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1692)
Gene editing (237)
Generative AI (75)
Gene therapy (743)
GLP-1 (1190)
Government (5494)
Grass and pollen (8)
Guidances (395)
Healthcare (20996)
HIV (78)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (316)
Immuno-oncology (87)
Indications (149)
Infectious disease (3349)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (277)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (103)
Layoffs (666)
Leadership (44)
Legal (10169)
Liver cancer (102)
Longevity (26)
Lung cancer (739)
Lymphoma (406)
Machine learning (54)
Management (66)
Manufacturing (979)
MASH (190)
Medical device (15126)
Medtech (15204)
Mergers & acquisitions (23078)
Metabolic disorders (1555)
mRNA (211)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (418)
Neuropsychiatric disorders (112)
Neuroscience (3352)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (73)
Obesity (760)
Opinion (352)
Ovarian cancer (181)
Pain (242)
Pancreatic cancer (260)
Parkinson's disease (350)
Partnered (39)
Patents (566)
Patient recruitment (588)
Peanut (65)
People (67288)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23996)
Phase 2 (33707)
Phase 3 (25381)
Pipeline (6734)
Policy (369)
Postmarket research (3554)
Preclinical (10777)
Press Release (72)
Prostate cancer (284)
Psychedelics (61)
Radiopharmaceuticals (323)
Rare diseases (1076)
Real estate (7445)
Recruiting (81)
Regulatory (29508)
Reports (72)
Research institute (2752)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (21)
RSV (93)
Schizophrenia (169)
Series A (286)
Series B (209)
Service/supplier (30)
Sickle cell disease (111)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (50)
Startups (4344)
State (2)
Stomach cancer (21)
Supply chain (125)
Tariffs (101)
The Weekly (131)
Vaccines (1206)
Venture capital (106)
Weight loss (519)
Women's health (112)
Worklife (23)
Date
Today (89)
Last 7 days (610)
Last 30 days (3241)
Last 365 days (32779)
2026 (7362)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (96)
Alaska (7)
Arizona (364)
Arkansas (15)
Asia (51781)
Australia (9098)
California (12544)
Canada (3554)
China (1278)
Colorado (534)
Connecticut (551)
Delaware (376)
Europe (119221)
Florida (1866)
Georgia (406)
Hawaii (4)
Idaho (68)
Illinois (1055)
India (83)
Indiana (588)
Iowa (24)
Japan (484)
Kansas (136)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1556)
Massachusetts (9195)
Michigan (383)
Minnesota (706)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (30)
Nevada (139)
New Hampshire (89)
New Jersey (3363)
New Mexico (33)
New York (3308)
North Carolina (1717)
North Dakota (10)
Northern California (6089)
Ohio (385)
Oklahoma (23)
Oregon (54)
Pennsylvania (2499)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (74)
South Dakota (1)
Southern California (4876)
Tennessee (201)
Texas (1993)
United States (45106)
Utah (379)
Vermont (1)
Virginia (318)
Washington D.C. (88)
Washington State (1034)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
There are 875,034 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Defence Therapeutics Announces Warrant Terms Amendment
March 20, 2026
·
3 min read
Events
Better Together: A Pharma & Biotech EHS Forum
This dynamic, one-day forum brings EHS experts in pharma and biotech together for a focused exchange on shared challenges and strategies shaping the future of EHS. Attendees will gain practical insights ranging from the growing role of AI and its operational implications to approaches for reducing risks in biosafety programs and minimizing chemical overuse. Designed for professionals in EHS, biosafety, lab operations, and compliance, this forum gives you a unique chance to connect with industry peers in life sciences, share best practices, and build professional relationships. Register today!
March 20, 2026
Layoff Tracker
Gossamer, BiomX Reveal Hefty Staff Cuts
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 20, 2026
·
39 min read
·
BioSpace Editorial Staff
Press Releases
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026
·
5 min read
Press Releases
BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT
March 20, 2026
·
2 min read
Press Releases
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
March 20, 2026
·
6 min read
Press Releases
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
March 20, 2026
·
2 min read
Press Releases
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
March 20, 2026
·
8 min read
Government
HHS Denies Disbandment of CDC Vaccine Advisory Group in Wake of Court Ruling
A spokesperson for the Department of Health and Human Services refuted the claim, made Thursday on social media by ACIP Vice Chair Robert Malone, calling it “baseless speculation.”
March 20, 2026
·
2 min read
·
Tristan Manalac
Policy
Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets
Biotech, in particular companies that are pre-commercial with a longer-duration risk profile, could be great investments as Operation Epic Fury rolls on, according to a Truist Securities analysis.
March 20, 2026
·
2 min read
·
Annalee Armstrong
1 of 87,504
Next
